These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 22074258
1. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. Hanwella R, Senanayake M, de Silva V. BMC Psychiatry; 2011 Nov 10; 11():176. PubMed ID: 22074258 [Abstract] [Full Text] [Related]
2. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. Stuhec M, Munda B, Svab V, Locatelli I. J Affect Disord; 2015 Jun 01; 178():149-59. PubMed ID: 25813457 [Abstract] [Full Text] [Related]
3. Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis. Rezaei G, Hosseini SA, Akbari Sari A, Olyaeemanesh A, Lotfi MH, Yassini M, Bidaki R, Nouri B. Med J Islam Repub Iran; 2016 Jun 01; 30():325. PubMed ID: 27390695 [Abstract] [Full Text] [Related]
4. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials. Liu Q, Zhang H, Fang Q, Qin L. J Clin Exp Neuropsychol; 2017 Nov 01; 39(9):854-865. PubMed ID: 28052720 [Abstract] [Full Text] [Related]
14. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P. Curr Med Res Opin; 2014 Aug 01; 30(8):1673-85. PubMed ID: 24627974 [Abstract] [Full Text] [Related]
15. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C, 31001074-ATT2001 Study Investigators. CNS Drugs; 2012 May 01; 26(5):421-34. PubMed ID: 22519922 [Abstract] [Full Text] [Related]
16. A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients. Bushe C, Day K, Reed V, Karlsdotter K, Berggren L, Pitcher A, Televantou F, Haynes V. J Psychopharmacol; 2016 May 01; 30(5):444-58. PubMed ID: 27005307 [Abstract] [Full Text] [Related]
17. Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B. Child Psychiatry Hum Dev; 2011 Jun 01; 42(3):257-69. PubMed ID: 21165694 [Abstract] [Full Text] [Related]